Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06873802 · ClinicalTrials.gov registry record
ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 20
- Enrollment target
NCT06873802: Completed study, sponsored by Mayo Clinic.
NCT06873802 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06873802 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study is being done to determine if a clinically available MRI sequence called ZTE imaging better visualizes breast biopsy markers made of bone cement compared to the currently used breast biopsy markers made of metal.
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-04-11 |
| Est. Completion | 2025-07-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06873802
The ClinicalTrials.gov registry entry for NCT06873802 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06873802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06873802 about?
NCT06873802 is a clinical study titled "ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers". This study is being done to determine if a clinically available MRI sequence called ZTE imaging better visualizes breast biopsy markers made of bone cement compared to the currently used breast biopsy markers made of metal.
What is the current status of trial NCT06873802?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2025-04-11. Estimated completion is 2025-07-25.
What interventions are being tested in trial NCT06873802?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06873802?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.